Notch regulates the angiogenic response via induction of VEGFR-1
暂无分享,去创建一个
Jan Kitajewski | Y. Funahashi | Yasuhiro Funahashi | J. Kitajewski | C. Shawber | Carrie J Shawber | Marina Vorontchikhina | Anshula Sharma | Hasina H Outtz | Anshula Sharma | H. Outtz | Marina Vorontchikhina
[1] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[2] A. Harris,et al. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. , 2006, Blood.
[3] M. Skobe,et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. , 2007, The Journal of clinical investigation.
[4] M. Fishman,et al. Gridlock signalling pathway fashions the first embryonic artery , 2001, Nature.
[5] M. Persico. Placenta Growth Factor , 2001 .
[6] Holger Gerhardt,et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.
[7] M. Kitamura,et al. Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.
[8] Y. Funahashi,et al. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor. , 1999, Oncology research.
[9] B. Gigante,et al. Plgf −/−eNos −/− mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] T. Noda,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Winer,et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.
[12] Christoph Dehio,et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 , 2003, Nature Medicine.
[13] N. Ferrara. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. , 2001, American journal of physiology. Cell physiology.
[14] Victoria L. Bautch,et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching , 2008, The Journal of cell biology.
[15] VEGF receptor signal transduction. , 2003, Science's STKE : signal transduction knowledge environment.
[16] M. Giacca,et al. Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels , 2007, Cell.
[17] Adrian L Harris,et al. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. , 2008, Microvascular research.
[18] Minhong Yan,et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.
[19] J. Rossant,et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.
[20] J. Kutok,et al. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. , 2004, The Journal of biological chemistry.
[21] Marcus Fruttiger,et al. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. , 2002, Investigative ophthalmology & visual science.
[22] Antonio Duarte,et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching , 2007, Proceedings of the National Academy of Sciences.
[23] E. Duh,et al. Upregulation of placental growth factor by vascular endothelial growth factor via a post‐transcriptional mechanism , 2005, FEBS letters.
[24] J. Campos-Ortega,et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.
[25] A. Luttun,et al. Placental Growth Factor (PlGF) and Its Receptor Flt‐1 (VEGFR‐1) , 2002 .
[26] T. Noda,et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.
[27] R. Tepper,et al. Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[28] Joseph B. Kearney,et al. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. , 2004, Blood.
[29] S. Rafii,et al. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.
[30] Freddy Radtke,et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.
[31] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[32] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[33] Jianzhong Huang,et al. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. , 2008, Cancer research.
[34] Till Acker,et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.
[35] Christian Fischer,et al. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.
[36] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[37] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[38] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.
[39] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[40] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[41] Wen Shi,et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. , 2007, Cancer research.
[42] J. Kutok,et al. Notch Oncoproteins Depend on γ-Secretase/Presenilin Activity for Processing and Function* , 2004, Journal of Biological Chemistry.
[43] J. Rakic,et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[44] M. Shibuya,et al. Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase , 2008, Japanese Journal of Ophthalmology.
[45] A. Luttun,et al. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. , 2002, Annals of the New York Academy of Sciences.
[46] Christopher C W Hughes,et al. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. , 2002, Microvascular research.
[47] R. Zimmermann,et al. Unique patterns of Notch1, Notch4 and Jagged1 expression in ovarian vessels during folliculogenesis and corpus luteum formation. , 2005, Gene expression patterns : GEP.